» Articles » PMID: 25930081

Colonic Mucosal Gene Expression and Genotype in Irritable Bowel Syndrome Patients with Normal or Elevated Fecal Bile Acid Excretion

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

The mucosal gene expression in rectosigmoid mucosa (RSM) in irritable bowel syndrome with diarrhea (IBS-D) is unknown. Our objectives were, first, to study mRNA expression [by RT(2) PCR of 19 genes pertaining to tight junctions, immune activation, intestinal ion transport and bile acid (BA) homeostasis] in RSM in IBS-D patients (n = 47) and healthy controls (n = 17) and study expression of a selected protein (PDZD3) in 10 IBS-D patients and 4 healthy controls; second, to assess RSM mRNA expression according to genotype and fecal BA excretion (high ≥ 2,337 μmol/48 h); and third, to determine whether genotype or mucosal mRNA expression is associated with colonic transit or BA parameters. Fold changes were corrected for false detection rate for 19 genes studied (P < 0.00263). In RSM in IBS-D patients compared with controls, mRNA expression of GUC2AB, PDZD3, and PR2Y4 was increased, whereas CLDN1 and FN1 were decreased. One immune-related gene was upregulated (C4BP4) and one downregulated (CCL20). There was increased expression of a selected ion transport protein (PDZD3) on immunohistochemistry and Western blot in IBS-D compared with controls (P = 0.02). There were no significant differences in mucosal mRNA in 20 IBS-D patients with high compared with 27 IBS-D patients with normal BA excretion. GPBAR1 (P < 0.05) was associated with colonic transit. We concluded that mucosal ion transport mRNA (for several genes and PDZD3 protein) is upregulated and barrier protein mRNA downregulated in IBS-D compared with healthy controls, independent of genotype. There are no differences in gene expression in IBS-D with high compared with normal fecal BA excretion.

Citing Articles

Tight junction protein changes in irritable bowel syndrome: the relation of age and disease severity.

Kim S, Choi J, Han M, Choi J, Park J, Kim M Korean J Intern Med. 2024; 39(6):906-916.

PMID: 39551069 PMC: 11569931. DOI: 10.3904/kjim.2024.097.


Gut Goo: Physiology, Diet, and Therapy of Intestinal Mucus and Biofilms in Gastrointestinal Health and Disease.

Damianos J, Abdelnaem N, Camilleri M Clin Gastroenterol Hepatol. 2024; 23(2):205-215.

PMID: 39426645 PMC: 11761393. DOI: 10.1016/j.cgh.2024.09.007.


Alterations of bile acid metabolism in patients with functional bowel disorders: a case-control study.

Polishchuk S, Neverovskyi A, Shypulin V Prz Gastroenterol. 2024; 18(4):442-448.

PMID: 38572453 PMC: 10985747. DOI: 10.5114/pg.2023.133062.


The alteration of mucosal bile acid profile is associated with nerve growth factor expression in mast cells and bowel symptoms in diarrhea-predominant irritable bowel syndrome.

Wu B, Xu P, Cheng L, Wang Q, Qiu H, Yan X Clin Exp Immunol. 2024; 216(2):200-210.

PMID: 38290436 PMC: 11036107. DOI: 10.1093/cei/uxae006.


Evidence of shared genetic factors in the etiology of gastrointestinal disorders and endometriosis and clinical implications for disease management.

Yang F, Wu Y, Hockey R, Doust J, Mishra G, Montgomery G Cell Rep Med. 2023; 4(11):101250.

PMID: 37909040 PMC: 10694629. DOI: 10.1016/j.xcrm.2023.101250.


References
1.
Camilleri M, Andrews C, Bharucha A, Carlson P, Ferber I, Stephens D . Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome. Gastroenterology. 2007; 132(1):17-25. PMC: 2474784. DOI: 10.1053/j.gastro.2006.11.020. View

2.
Vazquez-Roque M, Camilleri M, Smyrk T, Murray J, Marietta E, ONeill J . A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013; 144(5):903-911.e3. PMC: 3633663. DOI: 10.1053/j.gastro.2013.01.049. View

3.
Camilleri M, Nadeau A, Tremaine W, Lamsam J, Burton D, Odunsi S . Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil. 2009; 21(7):734-e43. PMC: 2705747. DOI: 10.1111/j.1365-2982.2009.01288.x. View

4.
Camilleri M, Carlson P, Acosta A, Busciglio I, Nair A, Gibbons S . RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study. Am J Physiol Gastrointest Liver Physiol. 2014; 306(12):G1089-98. PMC: 4059976. DOI: 10.1152/ajpgi.00068.2014. View

5.
Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha A . Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 2014; 307(5):G508-16. PMC: 4154122. DOI: 10.1152/ajpgi.00178.2014. View